These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
251 related items for PubMed ID: 15210062
1. Effect of simvastatin on endothelium-dependent vaso-relaxation and endogenous nitric oxide synthase inhibitor. Jiang JL, Jiang DJ, Tang YH, Li NS, Deng HW, Li YJ. Acta Pharmacol Sin; 2004 Jul; 25(7):893-901. PubMed ID: 15210062 [Abstract] [Full Text] [Related]
2. Epigallocatechin gallate preserves endothelial function by reducing the endogenous nitric oxide synthase inhibitor level. Tang WJ, Hu CP, Chen MF, Deng PY, Li YJ. Can J Physiol Pharmacol; 2006 Feb; 84(2):163-71. PubMed ID: 16900942 [Abstract] [Full Text] [Related]
3. Taurine protects against low-density lipoprotein-induced endothelial dysfunction by the DDAH/ADMA pathway. Tan B, Jiang DJ, Huang H, Jia SJ, Jiang JL, Hu CP, Li YJ. Vascul Pharmacol; 2007 May; 46(5):338-45. PubMed ID: 17293168 [Abstract] [Full Text] [Related]
4. Aspirin protected against endothelial damage induced by LDL: role of endogenous NO synthase inhibitors in rats. Deng S, Deng PY, Jiang JL, Ye F, Yu J, Yang TL, Deng HD, Li YJ. Acta Pharmacol Sin; 2004 Dec; 25(12):1633-9. PubMed ID: 15569408 [Abstract] [Full Text] [Related]
5. Probucol preserves endothelial function by reduction of the endogenous nitric oxide synthase inhibitor level. Jiang JL, Li Ns NS, Li YJ, Deng HW. Br J Pharmacol; 2002 Mar; 135(5):1175-82. PubMed ID: 11877324 [Abstract] [Full Text] [Related]
6. Relationship between protective effects of rosiglitazone on endothelium and endogenous nitric oxide synthase inhibitor in streptozotocin-induced diabetic rats and cultured endothelial cells. Wang S, Jiang JL, Hu CP, Zhang XJ, Yang DL, Li YJ. Diabetes Metab Res Rev; 2007 Feb; 23(2):157-64. PubMed ID: 16770837 [Abstract] [Full Text] [Related]
7. Relationship between protective effect of xanthone on endothelial cells and endogenous nitric oxide synthase inhibitors. Jiang DJ, Hu GY, Jiang JL, Xiang HL, Deng HW, Li YJ. Bioorg Med Chem; 2003 Nov 17; 11(23):5171-7. PubMed ID: 14604680 [Abstract] [Full Text] [Related]
8. Fenofibrate decreases asymmetric dimethylarginine level in cultured endothelial cells by inhibiting NF-kappaB activity. Yang TL, Chen MF, Luo BL, Xie QY, Jiang JL, Li YJ. Naunyn Schmiedebergs Arch Pharmacol; 2005 May 17; 371(5):401-7. PubMed ID: 15915325 [Abstract] [Full Text] [Related]
9. The inhibitory effect of simvastatin on the ADMA-induced inflammatory reaction is mediated by MAPK pathways in endothelial cells. Jiang JL, Wang S, Li NS, Zhang XH, Deng HW, Li YJ. Biochem Cell Biol; 2007 Feb 17; 85(1):66-77. PubMed ID: 17464346 [Abstract] [Full Text] [Related]
10. Dimethylarginine dimethylaminohydrolase inhibition and asymmetric dimethylarginine accumulation contribute to endothelial dysfunction in rats exposed to glycosylated protein: effects of aminoguanidine. Yin QF, Fu SH, He P, Xiong Y. Atherosclerosis; 2007 Jan 17; 190(1):53-61. PubMed ID: 16533509 [Abstract] [Full Text] [Related]
11. Demethylbellidifolin inhibits adhesion of monocytes to endothelial cells via reduction of tumor necrosis factor alpha and endogenous nitric oxide synthase inhibitor level. Jiang DJ, Jiang JL, Tan GS, Huang ZZ, Deng HW, Li YJ. Planta Med; 2003 Dec 17; 69(12):1150-2. PubMed ID: 14750034 [Abstract] [Full Text] [Related]
12. [Protective effect of losartan on injury induced by ox-LDL in endothelial cells and the relationship with asymmetric dimethylarginine]. Xie QY, Sun ZL, Chen MF, Yang TL. Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Feb 17; 31(1):66-9. PubMed ID: 16562679 [Abstract] [Full Text] [Related]
13. Novel mechanism for endothelial dysfunction: dysregulation of dimethylarginine dimethylaminohydrolase. Ito A, Tsao PS, Adimoolam S, Kimoto M, Ogawa T, Cooke JP. Circulation; 1999 Jun 22; 99(24):3092-5. PubMed ID: 10377069 [Abstract] [Full Text] [Related]
14. 17beta-estradiol preserves endothelial function by reduction of the endogenous nitric oxide synthase inhibitor level. Dai Z, Zhu HQ, Jiang DJ, Jiang JL, Deng HW, Li YJ. Int J Cardiol; 2004 Aug 22; 96(2):223-7. PubMed ID: 15262037 [Abstract] [Full Text] [Related]
15. Probucol decreases asymmetrical dimethylarginine level by alternation of protein arginine methyltransferase I and dimethylarginine dimethylaminohydrolase activity. Jiang JL, Zhang XH, Li NS, Rang WQ, Feng-Ye, Hu CP, Li YJ, Deng HW. Cardiovasc Drugs Ther; 2006 Aug 22; 20(4):281-94. PubMed ID: 16897158 [Abstract] [Full Text] [Related]
16. Effects of simvastatin and L-arginine on vasodilation, nitric oxide metabolites and endogenous NOS inhibitors in hypercholesterolemic subjects. Pereira EC, Bertolami MC, Faludi AA, Salem M, Bersch D, Abdalla DS. Free Radic Res; 2003 May 22; 37(5):529-36. PubMed ID: 12797474 [Abstract] [Full Text] [Related]
17. Role of asymmetric dimethylarginine in inflammatory reactions by angiotensin II. Chen MF, Xie XM, Yang TL, Wang YJ, Zhang XH, Luo BL, Li YJ. J Vasc Res; 2007 May 22; 44(5):391-402. PubMed ID: 17551258 [Abstract] [Full Text] [Related]
18. Asymmetric dimethylarginine determines the improvement of endothelium-dependent vasodilation by simvastatin: Effect of combination with oral L-arginine. Böger GI, Rudolph TK, Maas R, Schwedhelm E, Dumbadze E, Bierend A, Benndorf RA, Böger RH. J Am Coll Cardiol; 2007 Jun 12; 49(23):2274-82. PubMed ID: 17560293 [Abstract] [Full Text] [Related]
19. [Protective effect of insulin-like growth factor-1 on vascular endothelial function in hypercholesterolemia and the underlying mechanism]. Ji S, Ma Q, Luo X, Peng J. Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2013 Jan 12; 38(1):36-42. PubMed ID: 23406856 [Abstract] [Full Text] [Related]
20. Demethylbellidifolin preserves endothelial function by reduction of the endogenous nitric oxide synthase inhibitor level. Jiang DJ, Jiang JL, Zhu HQ, Tan GS, Liu SQ, Xu KP, Li YJ. J Ethnopharmacol; 2004 Aug 12; 93(2-3):295-306. PubMed ID: 15234768 [Abstract] [Full Text] [Related] Page: [Next] [New Search]